Back to Results
First PageMeta Content
Dendrimer / Financial markets / Antiseptics / Microbicides / Microbicides for sexually transmitted diseases / Short / Repurchase agreement / Finance / Microbiology / Financial economics


Healthcare & Biotech Update - Backing De-risked Biotech Advantage to gold standard, Believable managers, Cash Flow January 2015 Ranking of covered companies: Starpharma (SPL) - Buy Medical Developments (MVP) - Buy
Add to Reading List

Document Date: 2015-03-30 23:17:37

Open Document

File Size: 212,86 KB

Share Result on Facebook

City

Victoria / /

Company

PAC Partners / Disclaimer PAC Partners Pty Ltd. / Sienne Cancer Diagnostics / Sienna Cancer Diagnostics / Starpharma Holdings / Risk Rating PAC Partners / Phillip Capital Limited / ABC / Ansell / PAC Asset Management Pty Ltd / Anteo Diagnostics / Australian Biotechnology Sector / Dow Chemical / Vardon Ave Adelaide SA / /

Country

Japan / United States / /

Currency

USD / /

Event

FDA Phase / M&A / /

Facility

Neicon Tower / /

/

IndustryTerm

attractive broad applications / animal applications / platform technology / /

MedicalCondition

Bacterial Vaginosis / Recurrent Bacterial Vaginosis / /

MedicalTreatment

Dendrimer / Dendrimers / /

Organization

USDA / European Union / /

Person

Sydney Gold Coast Adelaide / William St Melbourne / /

/

Position

Author / Executive / Representative / analyst / /

Product

Dendrimer / Dendrimers / Avita / Vivagel ® Bacterial Vaginosis / Vivagel ® / /

Technology

Drug Delivery / Biosensors / Lasers / platform technology / /

SocialTag